541299 — Dr Lalchandani Labs Share Price
0.000.00%
Last trade - 00:00- IN₹50.09m
- IN₹58.18m
- IN₹48.10m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.54 | ||
| Price to Tang. Book | 0.56 | ||
| Price to Free Cashflow | 2.03 | ||
| Price to Sales | 1.25 | ||
| EV to EBITDA | 3.86 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.87% | ||
| Return on Equity | 9.26% | ||
| Operating Margin | 23.71% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | n/a | n/a | 50.4 | 48.09 | n/a | n/a | -4.58% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Dr Lalchandani Labs Limited is an India-based company, which is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, virology, cytology, other pathological investigations and immunoassay, immuno-histochemistry, molecular pathology, DNA and genetic testing. Through its integrated network, it offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The Company has its own blood banking services through its sister concern CPC blood bank. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
Directors
- Arjan Lalchandani CHM
- Mohit Lalchandani CEO
- Anchal Gupta CFO (35)
- Swati Poddar CCO
- Rajiv Handa IND
- Prakash Jhuraney IND
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- August 2nd, 2017
- Public Since
- May 9th, 2018
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 4,333,068
- Address
- M-20, GK -1, Greater Kailash-1,, New Delhi, 110048
- Web
- https://lalchandanipathlab.com/
- Phone
- +91 1149057058
- Auditors
- M/s.Jain Agarwal & Company
Upcoming Events for 541299
Dr Lalchandani Labs Ltd Annual Shareholders Meeting
Similar to 541299
Aashka Hospitals
Bombay Stock Exchange
Abate As Industries
Bombay Stock Exchange
Asarfi Hospital
Bombay Stock Exchange
Aspira Pathlab & Diagnostics
Bombay Stock Exchange
Broach Lifecare Hospital
Bombay Stock Exchange
FAQ
What is the Dr Lalchandani Labs share price?
As of Today at 20:19 UTC, shares in Dr Lalchandani Labs are trading at IN₹12.16. This share price information is delayed by 15 minutes.
How has the Dr Lalchandani Labs share price performed this year?
Shares in Dr Lalchandani Labs last closed at IN₹12.16 and the price had moved by -41.65% over the past 365 days. In terms of relative price strength the Dr Lalchandani Labs share price has underperformed the S&P BSE 100 Index by -45.03% over the past year.
What are the analyst and broker recommendations for Dr Lalchandani Labs?
There is no consensus recommendation for this security.
Find out moreWhat is the Dr Lalchandani Labs dividend yield?
Dr Lalchandani Labs does not currently pay a dividend.
Does Dr Lalchandani Labs pay a dividend?
Dr Lalchandani Labs does not currently pay a dividend.
When does Dr Lalchandani Labs next pay dividends?
Dr Lalchandani Labs does not currently pay a dividend.
How do I buy Dr Lalchandani Labs shares?
To buy shares in Dr Lalchandani Labs you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Dr Lalchandani Labs?
As of the previous close price of IN₹12.16, shares in Dr Lalchandani Labs had a market capitalisation of IN₹50.09m.
Where are Dr Lalchandani Labs shares listed?
Here are the trading details for Dr Lalchandani Labs:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 541299
What kind of share is Dr Lalchandani Labs?
Based on an overall assessment of its quality, value and momentum Dr Lalchandani Labs is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Dr Lalchandani Labs share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Dr Lalchandani Labs share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Dr Lalchandani Labs. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -31.4%.
As of the last closing price of IN₹12.16, shares in Dr Lalchandani Labs were trading -39.14% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Dr Lalchandani Labs PE Ratio?
The Dr Lalchandani Labs PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹12.16.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Dr Lalchandani Labs?
Dr Lalchandani Labs' management team is headed by:
- Arjan Lalchandani - CHM
- Mohit Lalchandani - CEO
- Anchal Gupta - CFO
- Swati Poddar - CCO
- Rajiv Handa - IND
- Prakash Jhuraney - IND